MTEX Mannatech Inc.

Video of Mannatech’s TruPLENISH™ Meal Replacement Shake Available on Business Wire’s Website

COPPELL, Texas--(BUSINESS WIRE)--

A video is available on Business Wire's Website featuring Mannatech®, Incorporated’s TruPLENISH Nutritional Supplement Shake and Mannatech’s Senior Global Wellness Director and Chairman of its Global Scientific Advisory Board, Dr. Steve Nugent.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160913006476/en/

Mannatech Inc., a global health and wellness company committed to transforming lives to make a better world, recently launched the TruPLENISH Shake as part of its new TruHealth™ Fat-Loss System, which is comprised of three groundbreaking wellness products to help target body fat. The TruPLENISH Shake is different from competitor shakes in that it is plant-based, gluten and dairy-free and is filled with vitamins, minerals, probiotics, Glyconutrients and over 20 grams of protein formulated to help improve body composition through the maintenance of lean muscle.* Unlike other meal replacement products, TruPLENISH doesn’t focus on simply lowering the scale but instead supports healthy weight management and digestion by nourishing the body with real food and nutrients while reducing caloric intake.

Watch the video to learn more.

*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

EN
13/09/2016

Underlying

MTEXMannatech Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Mannatech Inc.

 PRESS RELEASE
Free
MTEX MANNATECH INC.

Mannatech Announces Appointment of Robert A. Toth as Vice Chairman of ...

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ) announced that on November 20, 2024, the Board of Directors of Mannatech, Incorporated (the “Board”) appointed Robert A. Toth to the Board where he will serve as Vice Chairman of the Board of Mannatech, Incorporated (the "Company") effective December 1, 2024. Mr. Toth will serve as a Class III director of the Board. Mr. Toth previously served on the Company's Board between March 2008 through May 31, 2023. Mr. Toth previously served as the Chairman of the Compensation and Stock Option Plan Committee, served on the Audit Committee, the Nominat...

November 26, 2024 1 EN
 PRESS RELEASE
Free
MTEX MANNATECH INC.

Mannatech Reports Financial Results for Third Quarter 2024

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2024. Third Quarter Highlights Net sales for the quarter ended September 30, 2024 were $31.7 million, as compared to $32.6 million for the same period in 2023, a decrease of $0.9 million, or 2.5%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $0.4 million, or 1.2%, and unfavorable foreign exchange caused a $0.5 million decrease...

November 12, 2024 1 EN
 PRESS RELEASE
Free
MTEX MANNATECH INC.

Mannatech Reports Financial Results for Second Quarter 2024

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of 2024. Second Quarter Highlights Net sales for the quarter ended June 30, 2024 were $27.7 million, as compared to $32.6 million for the same period in 2023, a decrease of $4.9 million, or 14.9%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $4.2 million, or 12.9%, and unfavorable foreign exchange caused a $0.7 million decrease ...

August 13, 2024 1 EN
 PRESS RELEASE
Free
MTEX MANNATECH INC.

Mannatech Announces Appointment of James Clavijo as Chief Financial Of...

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical c...

July 1, 2024 1 EN
 PRESS RELEASE
Free
MTEX MANNATECH INC.

Mannatech Reports Financial Results for First Quarter 2024

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its first quarter of 2024. First Quarter Highlights Net sales for the quarter ended March 31, 2024 were $29.4 million, as compared to $34.1 million for the same period in 2023, a decrease of $4.7 million, or 13.8%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $3.9 million, or 11.3%, and unfavorable foreign exchange caused a $0.8 million decrease in GAAP net sales as compar...

May 14, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch